Financhill
Back

Keros Therapeutics Stock Predictions

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 10.9% based on the past 2 years of stock performance.
  • Keros Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $58.02. The Score for KROS is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 10.9% based on the past 2 years of stock performance.

Keros Therapeutics Stock Rating

Buy
81
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight selling pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
68.29
52-Week Low:
24.38

Prediction Charts

Market Cap:
1.6B
Price in USD:
58.02
Volume:
193.2K
Beta:
0.00

Technical Analysis

SMA50:
48.97
SMA100:
45.56
SMA200:
41.71
52-Wk Change:
37.07%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price isĀ 58.02 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-9 47.90 46.39 48.69 45.50
Jan-10 46.62 49.18 49.69 46.62
Jan-11 48.83 48.23 50.67 47.43
Jan-12 48.32 48.74 49.00 47.40
Jan-13 47.95 49.16 49.96 47.65
Jan-17 47.61 49.86 50.08 47.26
Jan-18 50.18 49.18 50.87 48.14
Jan-19 49.34 49.91 50.55 48.43
Jan-20 50.33 50.55 50.75 48.45
Jan-23 50.71 51.35 53.00 50.55
Jan-24 51.13 55.30 55.70 51.13
Jan-25 55.22 57.83 58.00 54.31
Jan-26 58.31 57.83 58.94 57.05
Jan-27 57.60 58.02 59.53 57.51

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.66 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.